MHIR and MaineHealth are actively trying to create drugs, devices, and other innovations that will help to advance medicine and help our patients. We look to commercial partners to move these ideas from our labs to the market. Here is a list of available technologies for license.

Inventor: Volkhard Lindner, MD, PhD

Summary of Invention: The present invention features compositions and methods for treating and preventing a metabolic syndrome featuring the collagen triple helix repeat containing-1 (Cthrc1) protein.

Patent Application #: 20140011737

Patent Application Status: filed January 9, 2014

For more information contact:
Todd Keiller
Technology Transfer
Maine Medical Center
Todd.Keiller@mainehealth.org

Inventors: Volkhard, Lindner, MD, PhD; Ilka Pinz, PhD; et al

Summary of Invention: The invention provides methods for the treatment of coronary heart disease, peripheral vascular disease, stroke, and ischemia featuring agents that interfere with the expression or activity of Cthrc1. The invention also provides the use of Cthrc1 peptide as a therapeutic agent for the treatment of acute or chronic cardiac deficiencies. The invention further provides detection and monitoring of Cthrc1 peptide in blood or serum to assess or monitor cardiac function.

Patent Application #: 20130059786

Patent Application Status: filed March 7, 2013

For more information contact:
Todd Keiller
Technology Transfer
Maine Medical Center
Todd.Keiller@mainehealth.org